These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27813531)

  • 41. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
    Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel immunoregulatory B cell pathways revealed by lpr-+ mixed chimeras.
    Sobel ES; Kakkanaiah VN; Schiffenbauer J; Reap EA; Cohen PL; Eisenberg RA
    J Immunol; 1998 Feb; 160(3):1497-503. PubMed ID: 9570572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.
    Chan O; Shlomchik MJ
    J Immunol; 1998 Jan; 160(1):51-9. PubMed ID: 9551955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I.
    Maldonado MA; Eisenberg RA; Roper E; Cohen PL; Kotzin BL
    J Exp Med; 1995 Feb; 181(2):641-8. PubMed ID: 7530760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. P2X7 purinergic receptor plays a critical role in maintaining T-cell homeostasis and preventing lupus pathogenesis.
    Mellouk A; Hutteau-Hamel T; Legrand J; Safya H; Benbijja M; Mercier-Nomé F; Benihoud K; Kanellopoulos JM; Bobé P
    Front Immunol; 2022; 13():957008. PubMed ID: 36248812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
    J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
    Giese T; Davidson WF
    J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular interactions in the lpr and gld models of systemic autoimmunity.
    Sobel ES
    Adv Dent Res; 1996 Apr; 10(1):76-80. PubMed ID: 8934931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Double negative (DN) αβ T cells: misperception and overdue recognition.
    Martina MN; Noel S; Saxena A; Rabb H; Hamad AR
    Immunol Cell Biol; 2015 Mar; 93(3):305-10. PubMed ID: 25420721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential roles of osteopontin/Eta-1 in early and late lpr disease.
    Weber GF; Cantor H
    Clin Exp Immunol; 2001 Dec; 126(3):578-83. PubMed ID: 11737079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV.
    Zörnig M; Grzeschiczek A; Kowalski MB; Hartmann KU; Möröy T
    Oncogene; 1995 Jun; 10(12):2397-401. PubMed ID: 7784089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice.
    Corneth OBJ; Schaper F; Luk F; Asmawidjaja PS; Mus AMC; Horst G; Heeringa P; Hendriks RW; Westra J; Lubberts E
    Sci Rep; 2019 Mar; 9(1):4032. PubMed ID: 30858513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of loss of NF-κB1, NF-κB2 or c-REL on SLE-like autoimmune disease and lymphadenopathy in Fas(lpr/lpr) mutant mice.
    Low JT; Hughes P; Lin A; Siebenlist U; Jain R; Yaprianto K; Gray DH; Gerondakis S; Strasser A; O'Reilly LA
    Immunol Cell Biol; 2016 Jan; 94(1):66-78. PubMed ID: 26084385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selection of anti-double-stranded DNA B cells in autoimmune MRL-lpr/lpr mice.
    Chen C; Li H; Tian Q; Beardall M; Xu Y; Casanova N; Weigert M
    J Immunol; 2006 May; 176(9):5183-90. PubMed ID: 16621982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of autoantibody production in lpr/lpr mice by transgenic expression of Fas on B cells.
    Shinohara N; Ikegami Y; Yokoyama M; Yonehara S; Komano H
    Ann N Y Acad Sci; 1997 Apr; 815():489-91. PubMed ID: 9186706
    [No Abstract]   [Full Text] [Related]  

  • 57. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
    Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
    J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.
    Campbell KJ; Bath ML; Turner ML; Vandenberg CJ; Bouillet P; Metcalf D; Scott CL; Cory S
    Blood; 2010 Oct; 116(17):3197-207. PubMed ID: 20631380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Langerhans Cells Maintain Local Tissue Tolerance in a Model of Systemic Autoimmune Disease.
    King JK; Philips RL; Eriksson AU; Kim PJ; Halder RC; Lee DJ; Singh RR
    J Immunol; 2015 Jul; 195(2):464-76. PubMed ID: 26071559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A genetic locus controlling aging-sensitive regression of B lymphopoiesis in an autoimmune-prone MRL/lpr strain of mice.
    Nakatani K; Qu WM; Zhang MC; Fujii H; Furukawa H; Miyazaki T; Iwano M; Saito Y; Nose M; Ono M
    Scand J Immunol; 2007 Dec; 66(6):654-61. PubMed ID: 17983422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.